Spectrum Pharma (SPPI) Misses Q3 EPS by 3c, Offers FY Guidace
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Eagle Pharmaceuticals and Spectrum Pharmaceuticals Announce Co-Promotion Agreement
November 4, 2015 4:02 PM ESTSpectrum Has Potential to Earn Up to $22 Million in Combination of Base Fee and Identified Milestone Payments
With Strong Pharmaceutical and Oncology Focused Expertise, Spectrums 32-Person Corporate Accounts Sales Team Poised to Commercialize up to Six Eagle Products
In Addition, Eagle to Hire up to 20 Direct Sales Representatives for a Total of 52; Agreement Facilitates Eagles Strategic Transition into Commercial Pharmaceutical Company
WOODCLIFF LAKE, N.J. & HENDERSON, Nev.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) (Eagle or the Company) and Spectrum Pharmaceuticals (NASDAQ:... More
